Browse Data and Analysis

Jordan’s biotechnology draft biosafety law based on the Cartagena Protocol on Biosafety, which among other issues mandates the labeling of biotech products, has yet to be approved since its drafting..

As of July 2015, Israel does not have a policy that restricts the use of imported biotech commodities or derivative products.